S. Stepanović, V. Djukić, V. Djordjević, S. Djukić 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Staphylococcus lugdunensis vertebral osteomyelitis
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Herpes zoster in non-hospitalized children
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
An eye-catching acanthocephalan
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Clinical Microbiology and Infection
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
Cephalosporins: a pharmacological update
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
Laboratory diagnosis and biosafety issues of biological warfare agents
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
G. Pappas  Clinical Microbiology and Infection 
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Metagenomics and probiotics
Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy  D. Nathwani, J.-J.
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Effect of antioxidants on the immune response of Helicobacter pylori
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Previously unknown species of Aspergillus
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
A. Bryskier  Clinical Microbiology and Infection 
Brucella detection in blood: comparison of the BacT/Alert standard aerobic bottle, BacT/Alert FAN aerobic bottle and BacT/Alert enhanced FAN aerobic bottle.
Pathogenesis of catheter-related infections: lessons for new designs
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
P.M. Hawkey  Clinical Microbiology and Infection 
Training in infectious diseases and tropical medicine in Britain
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Clinical infection services—the Leiden experience
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species  G. Kronvall, E. Holst  Clinical Microbiology.
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Carratalà J.   Clinical Microbiology and Infection 
B.A. Cunha  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Typing of Clostridium difficile
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Influence of the incubation atmosphere on the production of biofilm by staphylococci  S. Stepanović, V. Djukić, V. Djordjević, S. Djukić  Clinical Microbiology and Infection  Volume 9, Issue 9, Pages 955-958 (September 2003) DOI: 10.1046/j.1469-0691.2003.00676.x Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 The influence of the incubation atmosphere on the production of biofilm by four Staphylococcus species. Bars: the mean optical density (OD) ± SD of the biofilm formed by a particular strain of a species in different gaseous environments (▪, aerobic atmosphere; ▪, CO2 □, anaerobic atmosphere). Boxes and mathematical symbols (>, >): symbols denoting differences among mean OD values of the biofilm produced by all strains of a particular species in different gaseous environments (▪, aerobic atmosphere; ▪, CO2; □, anaerobic atmosphere). The differences were considered as significant if P > 0.05. Clinical Microbiology and Infection 2003 9, 955-958DOI: (10.1046/j.1469-0691.2003.00676.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions